Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis

SIMPLE SUMMARY: Poly (ADP-ribose) polymerase inhibitors (PARPis; inhibitors of a family of enzymes that are primary involved in DNA repair) are considered to be the drug of choice in maintenance therapy for platinum-sensitive ovarian cancer. However, despite the FDA approval of three such agents and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stemmer, Amos, Shafran, Inbal, Stemmer, Salomon M., Tsoref, Daliah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603267/
https://www.ncbi.nlm.nih.gov/pubmed/33081005
http://dx.doi.org/10.3390/cancers12103026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603267/
https://www.ncbi.nlm.nih.gov/pubmed/33081005
http://dx.doi.org/10.3390/cancers12103026

Ejemplares similares